Directorate change

Summary by AI BETAClose X

Reckitt Benckiser Group plc announces significant Directorate changes with the appointment of Harry Kirsch, former CFO of Novartis Pharma AG, and Deepak Nath, CEO of Smith+Nephew plc, as Non-Executive Directors effective April 1, 2026, while Margherita Della Valle and Mahesh Madhavan will retire from the Board on the same date. Harry Kirsch, who brings extensive finance experience from Novartis and Procter & Gamble, will also join the Audit Committee from May 2026. Deepak Nath's appointment adds considerable executive leadership from the medical technology sector. These changes are expected to bring valuable expertise to the Board.

Disclaimer*

UK 100

Latest directors dealings